Isocural (Isotretinoin)

Isotretinoin binds to retinoic acid receptors (RAR) and retinoid X receptors (RXR) in skin cells, altering gene expression. This reduces the size and activity of sebaceous glands, lowers sebum production, normalizes follicular keratinization, and exerts anti‑inflammatory effects, addressing the key pathogenic mechanisms of severe acne.

The dose of Isocural is individualized by the prescribing clinician based on the severity of acne, patient weight, and tolerance. Typical regimens start at a low dose and may be adjusted, but the exact amount and schedule must be determined by a qualified healthcare professional.

Isocural is classified as pregnancy category X because isotretinoin is highly teratogenic. It must not be used by pregnant women or by women who could become pregnant without effective contraception. Breastfeeding is also contraindicated, as the drug can be excreted in milk and affect the infant.

To order Isocural, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with oral antibiotics or hormonal therapy, isotretinoin offers a disease‑modifying effect rather than merely controlling symptoms. It provides long‑term remission after a finite course, whereas antibiotics require continuous use and carry resistance risks. Unlike topical retinoids, oral isotretinoin reaches deeper skin structures, delivering greater efficacy for severe nodular acne.

Isocural should be stored at temperatures below 25 °C in its original packaging, protected from moisture and direct light. Keep the medication out of reach of children and do not use if the seal is broken or the product appears discoloured.

Isocural is taken orally as a capsule, usually with a meal to improve absorption and reduce gastrointestinal irritation. The exact timing and whether it is taken once daily or divided doses are determined by the prescriber based on individual patient factors.

The most serious risks include teratogenicity (birth defects if exposure occurs during pregnancy), severe depression or mood changes, pancreatitis, and inflammatory bowel disease. Patients should be monitored closely for psychiatric symptoms, abdominal pain, and any signs of gastrointestinal inflammation.

Isocural should not be used by pregnant women, women planning pregnancy, or anyone who cannot use reliable contraception. It is also contraindicated in patients with pre‑existing liver disease, uncontrolled hyperlipidaemia, hypersensitivity to isotretinoin or other retinoids, and in individuals with a history of severe psychiatric disorders.